Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Craig Jordan

Showing results (131-140 of 218) with videos related to

Pageof 22
Sort By:
Frontiers in Endocrinology|April 1, 2022
Estrogen Receptor Complex to Trigger or Delay Estrogen-Induced Apoptosis in Long-Term Estrogen Deprived Breast CancerPhilipp Y Maximov, Ping Fan, Balkees Abderrahman, et al.
Molecular Cancer Research : MCR|January 19, 2019
Estrogen-Induced Apoptosis in Breast Cancers Is Phenocopied by Blocking Dephosphorylation of Eukaryotic Initiation Factor 2 Alpha (eIF2α) ProteinSurojeet Sengupta, Catherine M Sevigny, Poulomi Bhattacharya, et al.
Breast Cancer Research : BCR|January 9, 2009
By looking back we can see the way forward: enhancing the gains achieved with antihormone therapyV Craig Jordan, Roshani Patel, Joan S Lewis-Wambi, et al.
Molecular Cancer Therapeutics|September 19, 2018
Targeting Peroxisome Proliferator-Activated Receptor γ to Increase Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer CellsPing Fan, Balkees Abderrahman, Tina S Chai, et al.
Molecular and Cellular Endocrinology|June 9, 2015
The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapyPing Fan, Philipp Y Maximov, Ramona F Curpan, et al.
Biological Chemistry|September 16, 2006
Aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha in MCF-7 breast cancer cellsShengxi Liu, Maen Abdelrahim, Shaheen Khan, et al.
Plos One|June 12, 2013
Prolactin-induced protein (PIP) regulates proliferation of luminal A type breast cancer cells in an estrogen-independent mannerSanjeev K Baniwal, Nyam-Osor Chimge, V Craig Jordan, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2014
A molecular model for the mechanism of acquired tamoxifen resistance in breast cancerPing Fan, Fadeke A Agboke, Heather E Cunliffe, et al.
Hormone Molecular Biology and Clinical Investigation|January 12, 2013
Models and Mechanisms of Acquired Antihormone Resistance in Breast Cancer: Significant Clinical Progress Despite LimitationsElizabeth E Sweeney, Russell E McDaniel, Philipp Y Maximov, et al.
Cancer Research|April 17, 2004
Interaction of the aryl hydrocarbon receptor ligand 6-methyl-1,3,8-trichlorodibenzofuran with estrogen receptor alphaSandra Timm Pearce, Hong Liu, Ishwar Radhakrishnan, et al.
Pageof 22

Showing results (131-140 of 218) with videos related to

Sort By:
Pageof 22
Frontiers in Endocrinology|April 1, 2022
Estrogen Receptor Complex to Trigger or Delay Estrogen-Induced Apoptosis in Long-Term Estrogen Deprived Breast CancerPhilipp Y Maximov, Ping Fan, Balkees Abderrahman, et al.
Molecular Cancer Research : MCR|January 19, 2019
Estrogen-Induced Apoptosis in Breast Cancers Is Phenocopied by Blocking Dephosphorylation of Eukaryotic Initiation Factor 2 Alpha (eIF2α) ProteinSurojeet Sengupta, Catherine M Sevigny, Poulomi Bhattacharya, et al.
Breast Cancer Research : BCR|January 9, 2009
By looking back we can see the way forward: enhancing the gains achieved with antihormone therapyV Craig Jordan, Roshani Patel, Joan S Lewis-Wambi, et al.
Molecular Cancer Therapeutics|September 19, 2018
Targeting Peroxisome Proliferator-Activated Receptor γ to Increase Estrogen-Induced Apoptosis in Estrogen-Deprived Breast Cancer CellsPing Fan, Balkees Abderrahman, Tina S Chai, et al.
Molecular and Cellular Endocrinology|June 9, 2015
The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapyPing Fan, Philipp Y Maximov, Ramona F Curpan, et al.
Biological Chemistry|September 16, 2006
Aryl hydrocarbon receptor agonists directly activate estrogen receptor alpha in MCF-7 breast cancer cellsShengxi Liu, Maen Abdelrahim, Shaheen Khan, et al.
Plos One|June 12, 2013
Prolactin-induced protein (PIP) regulates proliferation of luminal A type breast cancer cells in an estrogen-independent mannerSanjeev K Baniwal, Nyam-Osor Chimge, V Craig Jordan, et al.
European Journal of Cancer (Oxford, England : 1990)|September 11, 2014
A molecular model for the mechanism of acquired tamoxifen resistance in breast cancerPing Fan, Fadeke A Agboke, Heather E Cunliffe, et al.
Hormone Molecular Biology and Clinical Investigation|January 12, 2013
Models and Mechanisms of Acquired Antihormone Resistance in Breast Cancer: Significant Clinical Progress Despite LimitationsElizabeth E Sweeney, Russell E McDaniel, Philipp Y Maximov, et al.
Cancer Research|April 17, 2004
Interaction of the aryl hydrocarbon receptor ligand 6-methyl-1,3,8-trichlorodibenzofuran with estrogen receptor alphaSandra Timm Pearce, Hong Liu, Ishwar Radhakrishnan, et al.
Pageof 22